0      0


Short Talk: The Next Generation Diarylquinoline TBAJ 587 has Superior Efficacy Against, and Restricts Selection of, Bedaquiline Resistant Rv0678 Mutants in a Mouse Model of Tuberculosis


Oct 4, 2020 12:24pm ‐ Oct 4, 2020 12:36pm



Credits: None available.

Speaker(s):

Credits

Credits: None available.

You must be logged in and own this session in order to post comments.